A GBT021601 ADME Microtracer Study in Healthy Volunteers

NCT05718687 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: GBT021601

Sponsor

Pfizer